|
||||||||||||||||
 |
||||||||||||||||
 |
||
 |
We are an Indo-US translational Biology Company focused on “Patient Segregation” in the area of cancer research. One of our core technologies was developed at Dana Faber Cancer Institute, Boston. Our R&D centre is located in Bangalore, India | |
| |
||
 |
 |
To develop personalized treatment option for cancer based on detailed molecular characterization and identification of key drivers of cancer progression and metastasis. |
|
To enable rational design of clinical trials with high rate of success. | |
 |
||
| |
||
 |
|
To become a top three biotechnology company in India by 2015. |
|
To become a top five biotechnology company in the world by 2020. | |
 |
||
| |
||
 |
|
To be a friend for the key stake holders in cancer treatment- Patients, Physicians and Pharmaceutical Companies. |
|
To enhance the quality of life of patient by selecting the most optimal treatment plan. |
|
|
To cut down drug development cost and time by identifying right drug combinations, and right patients for the drugs under development. |
|
 |
||
